Innovus Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Innovus Pharmaceuticals, Inc.
Thierry Laugel, managing partner of the Paris-based financiers, tells Scrip about the virtues of its 'company creation model,' giving innovative ideas time to mature rather than rushing to the market.
Innovus acquires Boston Topicals' ThermoMax hand warming cream in hot and warm formulations, BreastLife with amino acids to firm and lift women's breasts and HealthiFeet made with Knosis transdermal delivery system in a formulation firm says has been shown in a trial to increase temperature and blood flow in feet of diabetic patients. HealthiFeet will complement a product Innovus already offers and targets for consumers with diabetes, Diabases leg and foot relief topical.
Semma's $114m Series B round and a $107m Series C for Arcus top November's list of biopharmaceutical venture capital deals. Forty Seven, Medeor and Tricida also closed sizeable rounds.
Semma closed a $114m Series B round to fund development of insulin-producing cells. Also, Tesaro and Catalyst are among recent public company financings, while Otonomy shifted gears, laying off sales staff.
- OTC, Consumer
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Beyond Human, LLC
- FasTrack Pharmaceuticals, Inc.